REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma SIA (Latvia)

Main Activities: Research and Development in the Social Sciences and Humanities | Marketing Research and Public Opinion Polling
Full name: Swixx Biopharma SIA Profile Updated: December 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Swixx Biopharma SIA is a company based in Latvia, with its head office in Riga. It operates in the Research and Development in the Social Sciences and Humanities industry. The company was established on November 13, 2014. Swixx Biopharma SIA currently employs 23 (2023) people. From the latest financial highlights, Swixx Biopharma SIA reported a net sales revenue drop of 0.1% in 2024. Over the same period, its total assets grew by 33.84%. The net profit margin of Swixx Biopharma SIA increased by 0.13% in 2024.

Headquarters
Krisjana Valdemara iela 33A - 8A
Riga; Riga; Postal Code: 1010

Contact Details: Purchase the Swixx Biopharma SIA report to view the information.

Basic Information
Total Employees:
Purchase the Swixx Biopharma SIA report to view the information.
Registered Capital:
Purchase the Swixx Biopharma SIA report to view the information.
Financial Auditors:
Purchase the Swixx Biopharma SIA report to view the information.
Incorporation Date:
November 13, 2014
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-0.1%
Total operating revenue
-0.1%
Operating profit (EBIT)
-2.16%
EBITDA
-2.16%
Net Profit (Loss) for the Period
2.78%
Total Assets
33.84%
Total Equity
41.98%
Operating Profit Margin (ROS)
-0.13%
Net Profit Margin
0.13%
Return on Equity (ROE)
-11.28%
Quick Ratio
-21.65%
Cash Ratio
-5.97%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?